Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse."Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseActive, not recruitingPhase 22026-06-15NCT04998786

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Nantes University Hospital223

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre hospitalierStrasbourgFrance1
CH de la cote basqueBayonneFrance3
CH Lyon SudLyonFrance3
CHD les OudairiesLa Roche-sur-YonFrance1
CHRAnnecyFrance1
CHRUDijonFrance1
CHRURennesFrance1
CHRUNancyFrance4
Chru BretonneauToursFrance8
CHRU Hopital Haut LévêqueBordeauxFrance1
CHRU LilleLilleFrance32
CHUNantesFrance2
CHUCaenFrance5
CHUToulouseFrance2
CHULimogesFrance2
CHUClermont-FerrandFrance3
CHU Henri MondorParisFrance1
Hopital de l'archetNiceFrance1
Hopital St AntoineParisFrance1
Hôpital CochinParisFrance34
University HospitalPoitiersFrance3